Showing 20 of 10288 recruiting trials
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
👨⚕️ Jianchang He, Yunnan Provincial Hospital of Traditional Chinese Medicine📍 1 site📅 Started Aug 2025View details ↗
Study of How Safe and Effective Tarlatamab is in Brain Cancers
👨⚕️ Eric Chen, MD, Princess Margaret Cancer Centre/University Health Network📍 1 site📅 Started Aug 2025View details ↗
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia
👨⚕️ bing xing wang, M.D, The First Affiliated Hospital of University of Science and Technology of China📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07117045 ↗
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
👨⚕️ Ulka N Vaishampayan, University of Michigan Rogel Cancer Center📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07117227 ↗
Development and Validation of RCC Predicting Model With Emulated-target Trial
👨⚕️ Yongyue Wei, master, Peking University Health Science Center📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07260071 ↗
Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
👨⚕️ Manish Sinha, PhD, MRCP (UK), MRCPCH, King's College London📍 1 site📅 Started Aug 2025View details ↗
HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
RecruitingNCT07100405 ↗
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Prospective Opioid-Free AIS Fusion
👨⚕️ Michael Paloski, DO, OrthoCarolina Research Institute, Inc.📍 1 site📅 Started Aug 2025View details ↗
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →